905854-03-7
905854-03-7 structure
- Name: (3S,4S)-3-(5,6-Dihydro-4H-Pyrrolo[3,2,1-Ij]Quinolin-1-Yl)-4-(1H-Indol-3-Yl)Pyrrolidine-2,5-Dione
- Chemical Name: 2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3S,4S)
- CAS Number: 905854-03-7
- Molecular Formula: C23H19N3O2
- Molecular Weight: 369.41600
- Catalog: Research Areas Cancer
- Create Date: 2018-12-18 09:44:05
- Modify Date: 2025-09-12 19:06:02
-
(3S,4S)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (3S,4S)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1].
| Name | 2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3S,4S) |
|---|---|
| Synonyms |
(+-)-trans-2-Propylamino-cyclohexanol-(1)
(+)-3(S),4(S)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione 2-(propylamino)cyclohexanol (-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione (1R,2R)-2-(PROPYLAMINO)CYCLOHEXANOL |
| Description | (3S,4S)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (3S,4S)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C23H19N3O2 |
|---|---|
| Molecular Weight | 369.41600 |
| Exact Mass | 369.14800 |
| PSA | 66.89000 |
| LogP | 3.92140 |
| Storage condition | 2-8°C |
| Precursor 0 | |
|---|---|
| DownStream 1 | |
